APA (7th ed.) Citation

S, C., MK, K., HS, M., MJ, L., SK, K., HK, P., . . . SJ, C. (2026). Real-world effectiveness and safety of CGRP monoclonal antibodies in elderly migraine patients: A Korean multicenter study. The journal of headache and pain. https://doi.org/10.1186/s10194-026-02410-2

Chicago Style (17th ed.) Citation

S, Cho, et al. "Real-world Effectiveness and Safety of CGRP Monoclonal Antibodies in Elderly Migraine Patients: A Korean Multicenter Study." The Journal of Headache and Pain 2026. https://doi.org/10.1186/s10194-026-02410-2.

MLA (9th ed.) Citation

S, Cho, et al. "Real-world Effectiveness and Safety of CGRP Monoclonal Antibodies in Elderly Migraine Patients: A Korean Multicenter Study." The Journal of Headache and Pain, 2026, https://doi.org/10.1186/s10194-026-02410-2.